Development of 99mTc-EC-tyrosine for Early Detection of Breast Cancer Tumor Response to the Anticancer Drug Melphalan
- 31 January 2013
- journal article
- Published by Elsevier BV in Academic Radiology
- Vol. 20 (1), 41-51
- https://doi.org/10.1016/j.acra.2012.08.005
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Correlation of L‐type amino acid transporter 1 and CD98 expression with triple negative breast cancer prognosisCancer Science, 2011
- The role of FDG PET/CT in patients with locoregional breast cancer recurrence: A comparison to conventional imaging techniquesEuropean Journal of Surgical Oncology, 2010
- Prognostic significance of L‐type amino acid transporter 1 (LAT1) and 4F2 heavy chain (CD98) expression in early stage squamous cell carcinoma of the lungCancer Science, 2009
- Pharmacokinetic role of L-type amino acid transporters LAT1 and LAT2European Journal of Pharmaceutical Sciences, 2008
- Non-natural amino acids for tumor imaging using positron emission tomography and single photon emission computed tomographyCancer and Metastasis Reviews, 2008
- FDG PET/CT for the Detection and Evaluation of Breast Diseases: Usefulness and LimitationsRadioGraphics, 2007
- False-Positive FDG PET Uptake−the Role of PET/CTEuropean Radiology, 2005
- Down-Regulation of CD98 in Melphalan-Resistant Myeloma Cells with Reduced Drug UptakeActa Haematologica, 2000
- High-dose intravenous melphalan: a review.Journal of Clinical Oncology, 1995
- Decreased melphalan accumulation in a human breast cancer cell line selected for resistance to melphalanBritish Journal of Cancer, 1993